Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • madmanshooter madmanshooter Sep 6, 2006 10:53 AM Flag

    Is it that bad?

    No that is not the case. The issue is the additional costs for GHDX in securing required approvals. The product continues to be used and marketed and the market for it continues to grow. Whether that will increase substantially once the registration as a medical device issue is resolved remains to be seen. Today's price action is typical, this stock moves a great deal, on occasion, on relatively little news.

 
GHDX
30.38-0.84(-2.69%)Apr 17 4:00 PMEDT